• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

What dermatologists could do to cope with the novel coronavirus (SARS‐CoV‐2): a dermatologist’s perspective from China

 
Thumbnail
Date
2020-03-27
Author
Zhang, H. et al.
Metadata
Show full item record
Abstract
Dear Editor, Coronavirus disease, first emerged in Wuhan, China, rapidly spread all over the country since December 2019. Up to now, the epidemic situation in China remains stable, while the global march of the virus is seemingly unstoppable, especially in South Korea, Iran and Italy. Here, we reported what dermatologists could do to cope with novel coronavirus from a Chinese dermatologist’s perspective. Dermatologists in epidemic areas may receive and cure confirmed or suspected patients in dermatological wards. Tao et al. recommended emergency management plans in dermatology departments. Suspected or confirmed novel coronavirus patients should be strictly handled according to rules and regulations on nosocomial infection. Zhang et al. identified self‐reported drug hypersensitivity (11.4%) and urticaria (1.4%) in 140 patients infected by novel coronavirus. Teleconsultation could be provided by dermatologists; if it is not effective, bedside consultation is needed. In outpatient and emergency in the department of dermatology, pre‐examination and triage are needed to differentiate patients with fever. Patients with symptoms of fever, cough and dyspnoea, with or without epidemiological contact history, should be referred to the fever clinic. Dermatologists should participate in the diagnosis and treatment of patients who have fever and rash after pre‐examination and triage. Strict protection to prevent cross‐infection should be re‐emphasized. [...]
URI
https://doi.org/10.1111/jdv.16389
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)